YD Bio Limited (NASDAQ:YDES – Get Free Report)’s stock price traded down 9.9% during mid-day trading on Thursday . The company traded as low as $11.03 and last traded at $11.03. 58,150 shares traded hands during trading, a decline of 3% from the average session volume of 59,873 shares. The stock had previously closed at $12.24.
Wall Street Analysts Forecast Growth
A number of research firms recently issued reports on YDES. Wall Street Zen upgraded shares of YD Bio to a “sell” rating in a research report on Tuesday, November 4th. Weiss Ratings reiterated a “sell (d+)” rating on shares of YD Bio in a research note on Monday, December 29th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, YD Bio currently has an average rating of “Sell”.
Check Out Our Latest Research Report on YDES
YD Bio Stock Up 7.6%
About YD Bio
YD Bio Limited is a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations.
Featured Stories
- Five stocks we like better than YD Bio
- Do not delete, read immediately
- NEW LAW: Congress Approves Setup For Digital Dollar?
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- A U.S. “birthright” claim worth trillions – activated quietly
- The Crash Has Already Started (Most Just Don’t See It Yet)
Receive News & Ratings for YD Bio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for YD Bio and related companies with MarketBeat.com's FREE daily email newsletter.
